Masters in Biomedical Engineering

University College Dublin

Ireland, Dublin

University RankQS Ranking

127

Apply Now!

Go to Official Website

Home/Ireland/Dublin /University College Dublin/Masters in Biomedical Engineering

University College Dublin

Ireland , Dublin

Key Facts

Program Level

Master by Course Work

Study Type

Full Time

Delivery

On Campus

Campuses

Main Site

Program Language

English

Start & Deadlines

Next Intake Deadlines25-Sep-2026

Apply to this program

Go to the official application for the university

Duration 2 year(s)

Tuition Fee

EUR 29,100 / year(s)

Next Intake 25-Sep-2026

Masters in Biomedical Engineering

About

There are currently 250 medical technology companies in Ireland, exporting €12.6 billion worth of product annually and employing 38,000 people – the highest number of people working in the industry in any country in Europe, per head of population.

Biomedical Engineering involves the application of engineering principles to healthcare and medicine. It is an interdisciplinary field, requiring knowledge of both living systems and engineering.

When studying on this programme, you will work with staff and researchers at UCD who have extensive experience in ground-breaking biomedical engineering research. You will also develop a knowledge of how the medical device industry is regulated and how new products are introduced to the market, drawing from experience within UCD which includes pioneering companies.

For more information visit www.ucd.ie/biomedicalengineering/

Module Information:

Under the "What modules can I take?" section below you will see general module information, for a more detailed description including module selection rules click here.

Requirements

Entry Requirements

An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a Mechanical, Electronic, Electrical, Mechatronic, Bioengineering or Biomedical Engineering programme is required.
Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.
These are the minimum entry requirements – additional criteria may be requested for some programmes

You may be eligible for Recognition of Prior Learning (RPL), as UCD recognises formal, informal, and/or experiential learning. RPL may be awarded to gain Admission and/or credit exemptions on a programme. Please visit the UCD Registry RPL web page for further information. Any exceptions are also listed on this webpage.

English Program Requirements

International English Language Testing System (IELTS)

Taught Master's: A minimum overall score of 7.0 over all components and a minimum of 6.0 in each band on the Academic Version. The non-academic version is not accepted.

Research Programmes: A minimum overall score of 6.5 over all components and a minimum of 6.0 in each band on the Academic Version. The non-academic version is not accepted.

IELTS Indicator: A minimum overall score of 7.0 over all components and a minimum of 6.0 in each band. This test will be accepted for 2022/23 and 2023/24 intake.

Test of English as a Foreign Language (TOEFL)

Taught Master's: A minimum score of 100 is required in the Internet based TOEFL (iBT) with a score of at least 20 in each section.

Research Programmes: A minimum score of 90 is required in the Internet based TOEFL (iBT) with a score of at least 20 in each section.

TOEFL iBT Home: A minimum score of 100 is required with a score of at least 20 in each section.

Duolingo Test of English (DET)

UCD has approved the use of the Duolingo Test of English (DET) for the 2024/25 intake.
An overall score of 130 will be accepted with no section below 110.

Please note that this does not apply to the CEMS MiM / MSc in International Management. In the case of the CEMS MiM the Duolingo English Test will not be accepted.

Career

The Irish Medtech Sector is robust and career opportunities upon graduation from this programme are exemplary. Exports of medical devices and diagnostics products now represent 8% of Ireland’s total merchandise exports and growth prospects for the industry globally remain good. Many of the world’s top medical technology companies have invested significantly in Ireland and a number of exciting, research-based, indigenous companies are emerging and competing internationally.

The Irish Government has identified the medical technology sector as one of the key drivers of industrial growth for the future and provides a wide range of supports to encourage and foster this growth. The medical technology industry in Ireland is changing from being predominantly manufacturing to being more complex and driven by R&D. Prospective employers include Abbott, Bio-Medical Research (BMR), Boston Scientific, De Puy, ResMed, Shimmer and Stryker.